Spain · AEMPS CIMA

ABACAVIR/LAMIVUDINA GLENMARK 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
82591
Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Composition / generic term
abacavir + lamivudina
Source strength
600 mg/300 mg
Authorisation holder
Glenmark Arzneimittel Gmbh
Marketed in source snapshot
Yes

Source-listed ingredients

  • ABACAVIR CLORHIDRATO — 676.401 mg
  • LAMIVUDINA — 300 mg

These values do not establish equivalence or a dose recommendation.

Packages

  • ABACAVIR/LAMIVUDINA GLENMARK 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos (Blister PVC/Aclar/Al)
  • ABACAVIR/LAMIVUDINA GLENMARK 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos (Blister PVD/PVDC/Al)

Source and coverage

Open AEMPS CIMA →

Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Spain records →